1. Home
  2. HAE vs CDP Comparison

HAE vs CDP Comparison

Compare HAE & CDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HAE
  • CDP
  • Stock Information
  • Founded
  • HAE 1971
  • CDP 1988
  • Country
  • HAE United States
  • CDP United States
  • Employees
  • HAE N/A
  • CDP N/A
  • Industry
  • HAE Medical/Dental Instruments
  • CDP Real Estate Investment Trusts
  • Sector
  • HAE Health Care
  • CDP Real Estate
  • Exchange
  • HAE Nasdaq
  • CDP Nasdaq
  • Market Cap
  • HAE 3.3B
  • CDP 3.1B
  • IPO Year
  • HAE 1991
  • CDP N/A
  • Fundamental
  • Price
  • HAE $54.56
  • CDP $28.70
  • Analyst Decision
  • HAE Buy
  • CDP Strong Buy
  • Analyst Count
  • HAE 11
  • CDP 5
  • Target Price
  • HAE $86.73
  • CDP $33.60
  • AVG Volume (30 Days)
  • HAE 1.3M
  • CDP 806.6K
  • Earning Date
  • HAE 08-07-2025
  • CDP 10-27-2025
  • Dividend Yield
  • HAE N/A
  • CDP 4.25%
  • EPS Growth
  • HAE 46.89
  • CDP N/A
  • EPS
  • HAE 3.28
  • CDP 1.27
  • Revenue
  • HAE $1,346,046,000.00
  • CDP $751,457,000.00
  • Revenue This Year
  • HAE N/A
  • CDP N/A
  • Revenue Next Year
  • HAE $6.50
  • CDP $4.56
  • P/E Ratio
  • HAE $16.62
  • CDP $22.57
  • Revenue Growth
  • HAE 0.91
  • CDP 3.13
  • 52 Week Low
  • HAE $50.68
  • CDP $23.92
  • 52 Week High
  • HAE $94.99
  • CDP $34.22
  • Technical
  • Relative Strength Index (RSI)
  • HAE 33.12
  • CDP 60.87
  • Support Level
  • HAE $53.90
  • CDP $28.56
  • Resistance Level
  • HAE $56.64
  • CDP $29.08
  • Average True Range (ATR)
  • HAE 1.64
  • CDP 0.41
  • MACD
  • HAE 0.46
  • CDP 0.11
  • Stochastic Oscillator
  • HAE 65.10
  • CDP 76.72

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

About CDP COPT Defense Properties of Beneficial Interest

COPT Defense Properties is a fully-integrated and self-managed real estate investment trust (REIT) focused on owning, operating and developing properties in locations proximate to, or sometimes containing, key U.S. Government (USG) defense installations and missions. Its tenants include the USG and their defense contractors, who are engaged in priority national security activities, and who generally require mission-critical and high security property enhancements. Its properties include 195 operating properties totaling approximately 22.4 million square feet comprised of 16.5 million square feet in 164 office properties and 5.9 million square feet in 31 single-tenant data center shells.

Share on Social Networks: